Company attributes
Industry
B2X
0
CEO
AngelList URL
Pitchbook URL
Legal Name
Cyclacel Pharmaceuticals, Inc.
Legal classification
Date Incorporated
August 13, 1996
Number of Employees (Ranges)
11 – 50
Email Address
info@cyclacel.com0
recruitment@cyclacel.com0
bdev@cyclacel.com0
ir@cyclacel.com0
Phone Number
+190851773300
Full Address
New Bridge Street House, 30-34 New Bridge Street, London, EC4V 6BJ
200 Connell Drive #1500 Berkeley Heights, NJ 07922 United States of America0
CIK Number
Place of Incorporation
Incorporation Reference
03237549
Investors
DUNS Number
9478309310
IRS Number
911,766,8500
Founded Date
2000
0Fax Number
+1 (866) 271 34660
Total Funding Amount (USD)
7,000,000
Latest Funding Round Date
January 2021
Stock Symbol
CYCC0
Exchange
Board of Directors
CFO
Also Known As
Cyclacel Limited
NAICS Code
325,4120
CAGE Code
5NGH00
Patents Assigned (Count)
1
COO
Wellfound ID
Country
Headquarters
Other attributes
Company Operating Status
Active
Contact Page URL
Previous Name
XCYTE THERAPIES INC0
SIC Code
2,8340
Ticker Symbol
CYCC
UKSIC Code
72110
Wikidata ID
Cyclacel Pharmaceuticals is a clinical-stage, biopharmaceutical company, that develops innovative cancer medicines based on cell cycle, transcriptional regulation, and mitosis biology. Cyclacel builds a diversified biopharmaceutical business based on a pipeline of novel drug candidates to address oncology and hematology indications.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
